JPWO2022040141A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022040141A5 JPWO2022040141A5 JP2023511926A JP2023511926A JPWO2022040141A5 JP WO2022040141 A5 JPWO2022040141 A5 JP WO2022040141A5 JP 2023511926 A JP2023511926 A JP 2023511926A JP 2023511926 A JP2023511926 A JP 2023511926A JP WO2022040141 A5 JPWO2022040141 A5 JP WO2022040141A5
- Authority
- JP
- Japan
- Prior art keywords
- sustained release
- release formulation
- pharmaceutical ingredients
- active pharmaceutical
- hyaluronic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063066547P | 2020-08-17 | 2020-08-17 | |
| US63/066,547 | 2020-08-17 | ||
| PCT/US2021/046237 WO2022040141A1 (en) | 2020-08-17 | 2021-08-17 | Long acting in-situ forming/gelling compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538075A JP2023538075A (ja) | 2023-09-06 |
| JPWO2022040141A5 true JPWO2022040141A5 (ko) | 2023-11-09 |
Family
ID=80224713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023511926A Pending JP2023538075A (ja) | 2020-08-17 | 2021-08-17 | 長時間作用のインサイチュ形成／ゲル化組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220047566A1 (ko) |
| EP (1) | EP4196109A4 (ko) |
| JP (1) | JP2023538075A (ko) |
| KR (1) | KR20230052921A (ko) |
| CN (1) | CN116669717A (ko) |
| AU (1) | AU2021328260A1 (ko) |
| CA (1) | CA3189272A1 (ko) |
| WO (1) | WO2022040141A1 (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116041342B (zh) * | 2022-12-30 | 2024-02-20 | 加立(深圳)生物科技有限公司 | 罗哌卡因/美洛昔康盐的一水合物i晶型、药物组合物及其制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070224278A1 (en) * | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
| US8940311B2 (en) * | 2004-10-21 | 2015-01-27 | Tae-Hong Lim | In situ controlled release drug delivery system |
| US20100233272A1 (en) * | 2007-11-15 | 2010-09-16 | Leah Elizabeth Appel | Dosage forms comprising celecoxib providing both rapid and sustained pain relief |
| US8846068B2 (en) * | 2008-04-18 | 2014-09-30 | Warsaw Orthopedic, Inc. | Methods and compositions for treating post-operative pain comprising a local anesthetic |
| GB2513060B (en) * | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
| IT1402786B1 (it) * | 2010-11-19 | 2013-09-18 | Fidia Farmaceutici | Composizioni farmaceutiche ad attivita' antibatterica e cicatrizzante |
| US11666531B2 (en) * | 2016-03-31 | 2023-06-06 | Smartech Topical, Inc. | Delivery system |
| EP3452031A4 (en) * | 2016-05-05 | 2019-12-11 | Liquidia Technologies, Inc. | PRECISION-CONTROLLED LOADING AND RELEASE PARTICLES FOR POST-OPERATIONAL PAIN |
| WO2020232539A1 (en) * | 2019-05-17 | 2020-11-26 | The Governing Council Of The University Of Toronto | Sustained release local anesthetic hydrogel composition |
| MX2021014477A (es) * | 2019-05-29 | 2022-01-06 | Lupin Ltd | Nanoemulsion gelificante in situ de brinzolamida. |
-
2021
- 2021-08-17 JP JP2023511926A patent/JP2023538075A/ja active Pending
- 2021-08-17 KR KR1020237008665A patent/KR20230052921A/ko active Search and Examination
- 2021-08-17 CA CA3189272A patent/CA3189272A1/en active Pending
- 2021-08-17 US US17/404,358 patent/US20220047566A1/en active Pending
- 2021-08-17 CN CN202180068067.7A patent/CN116669717A/zh active Pending
- 2021-08-17 EP EP21858937.2A patent/EP4196109A4/en active Pending
- 2021-08-17 WO PCT/US2021/046237 patent/WO2022040141A1/en active Application Filing
- 2021-08-17 AU AU2021328260A patent/AU2021328260A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101809713B1 (ko) | 방부제 없는 프로스타글란딘계 비점성 용액의 고분자 전달 시스템 | |
| JP6312921B2 (ja) | ５−アルファ還元酵素抑制剤を含む医薬組成物 | |
| CA2974657C (en) | Injectable pharmaceutical composition comprising dexamethasone sodium phosphate | |
| CA2891218A1 (en) | Aqueous based capsaicinoid formulations and methods of manufacture and use | |
| EP3982973A1 (en) | Pain relieving method | |
| US11426418B2 (en) | Injectable long-acting semi-solid gel formulations | |
| JPWO2022040141A5 (ko) | ||
| WO2016182032A1 (ja) | アゾール系抗真菌薬の眼瞼皮膚への投与 | |
| JP2023099169A (ja) | 多標的阻害剤の医薬 | |
| KR20130089522A (ko) | 비강 내 지혈용 조성물 | |
| JP2023538075A (ja) | 長時間作用のインサイチュ形成／ゲル化組成物 | |
| JPH03291222A (ja) | ジクロフェナック・ナトリウムを含有する局所用医薬組成物 | |
| MX2012006352A (es) | Tratamiento de alodinia e hiperalgesia. | |
| TWI463980B (zh) | 醫藥組成物 | |
| KR20170095839A (ko) | 피부 장애의 치료를 위한 3-(피페리딘-4-일)-이속사졸-3(2h)-온 | |
| WO2008015190A2 (en) | Treatment and prevention of excessive scarring | |
| JP2016531872A (ja) | 萎縮性皮膚瘢痕を治療するためのプロスタグランジンＦ２α及びその類似体 | |
| JP2022552252A (ja) | 爪真菌症治療用組成物及び方法 | |
| JP7299683B2 (ja) | 皮膚外用組成物 | |
| JP2005089345A (ja) | 虫刺され治療薬 | |
| TW202222348A (zh) | 皮膜形成噴霧組合物及噴霧型皮膜形成外用製劑 | |
| BR112021011504A2 (pt) | Composição que compreende dutasterida | |
| JP2021008450A (ja) | 角層修復促進剤 | |
| WO2020049327A1 (en) | Methods and pharmaceutical composition for the treatment of hidradenitis suppurativa in patients in need thereof | |
| JP2013512888A (ja) | 異痛および痛覚過敏の治療 |